Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9385708 | Respiratory Medicine | 2005 | 7 Pages |
Abstract
In stable patients with COPD, treatment with inhaled budesonide for a period of 6 months has a positive effect on markers of lung inflammation, as assessed by reduction in percentage neutrophils and IL-8 concentration in BAL.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Duygu Ozol, Tulin Aysan, Zeynep Aytemur Solak, Nesrin Mogulkoc, Ali Veral, Filiz Sebik,